EXO 098
Alternative Names: EXO-098Latest Information Update: 25 Jun 2021
At a glance
- Originator Coya Therapeutics
- Class Exosome therapies; Proteins; RNA; Skin disorder therapies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Scleroderma